COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,653 Articles (22,459 medRxiv, 8,194 bioRxiv)

Most recent first Previous |  Page 24: Articles 231-240  | Next

COVID-19 vaccination induces cross-neutralisation of sarbecoviruses related to SARS-CoV-2
West, G., Morse, R., Sievers, B. L., Abdullahi, A., Kamelian, K., Cheng, M., Bioresource, C. N., Stewart, D., David, D., Robertson, D. L., Lytras, S., Wilson, S. J., Rihn, S. J., Gupta, R. K.
10.1101/2025.04.04.647203 — Posted: 2025-04-07
Intranasal sarbecovirus vaccine booster elicits cross-clade, durable and protective systemic and mucosal immunity
CHEANG, N. Y. Z., YAP, W. C., TULLETT, K. M., Qian, X., TAN, P. S., Purushotorman, K., TAN, W. Y., MAH, S. Y. Y., MacAry, P. A., TAN, C. W., Lahoud, M. H., ALONSO, S.
10.1101/2025.04.04.647326 — Posted: 2025-04-07
An updated dataset of early SARS-CoV-2 diversity supports a wildlife market origin
Hensel, Z., Debarre, F.
10.1101/2025.04.05.647275 — Posted: 2025-04-07
Stoichiometric Insights into SARS-CoV-2 Spike-ACE2 Binding Across Variants
Akinwumi, I. A., Bheemireddy, S., CHALOIN, L., Perez, S., Khakzad, H., Maigret, B., Karami, Y.
10.1101/2025.04.04.647209 — Posted: 2025-04-07
Geospatial and demographic patterns of SARS-CoV-2 spread in Massachusetts from over 130,000 genomes
Moreno, G. K., Brock-Fisher, T., Krasilnikova, L. A., Schaffner, S., Burns, M., Casiello, C. E., Messer, K. S., Petros, B. A., Specht, I., DeRuff, K. C., Siddle, K. J., Loreth, C., Fitzgerald, N. A., Rooke, H. M., Gabriel, S. B., Smole, S., Wohl, S., Park, D. J., Madoff, L. C., Brown, C. M., MacInnis, B. L., Sabeti, P. C.
10.1101/2025.04.04.25324273 — Posted: 2025-04-06
Mental symptoms in Post-COVID Syndrome (PCS) and Post-COVID-19 vaccination syndrome (PCVS): results of a representative population survey
Czaplicki, A., Hipper, L., Hegerl, U.
10.1101/2025.04.02.25325121 — Posted: 2025-04-06
Efficacy of colchicine with or without corticosteroids in hospitalized COVID-19 patients: A systematic review and meta-analysis
Arthur, M. D., Wilson, J., Cai, E., See, J., Peterson, B. M., Galbadage, T.
10.1101/2025.04.04.25325283 — Posted: 2025-04-06
Impact of extending lockdown on COVID-19 dynamic during 2021 in London: a mathematical modelling study
Ramdani, N.
10.1101/2025.04.02.25325123 — Posted: 2025-04-04
Assessment of Nirmatrelvir-Ritonavir Effects on Acute and Post-Acute COVID-19 Illness in US Adolescents: Target Trial Emulation
Shen, Y., Zhang, B., Jhaveri, R., Tong, J., ZHOU, T., Chen, J., Zhang, D., Wu, Q., Zang, C., Wang, F., Kaushal, R., Newland, J. G., Taylor, E., Herring, S. J., Bisyuk, Y., Liebovitz, D. M., Kim, S., Fort, D., Williams, D. A., Horne, B. D., Cummins, M., Liu, M., Chrischilles, E. A., Cowell, L. G., Mosa, A. S. M., Patel, P., Forrest, C. B., Chen, Y.
10.1101/2025.04.02.25324861 — Posted: 2025-04-04
Sickness Absence Rates in NHS England Staff during the COVID-19 Pandemic: insights from multivariate regression and time series modelling
McTaggart, E., Megiddo, I., Bowers, J., Kleczkowski, A.
10.1101/2025.04.02.25325152 — Posted: 2025-04-04

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).